Abstract:BACKGROUND:Major depressive disorder (MDD) is twice more prevalent in females than in males. Yet, there have only been a few studies on the functional brain activity in female MDD patients and the detailed mechanisms underlying their neurobiology merit further investigations. In the present work, we used combined fMRI-MRS methods to investigate the altered intrinsic neuronal activity and its association with neurotransmitter concentration in female MDD patients. METHODS:The whole brain amplitude of low frequency fluctuation (ALFF) analysis using resting state functional magnetic resonance imaging (fMRI) was performed to explore the alteration of intrinsic neuronal signals in MDD females (n=11) compared with female healthy controls (n=11). With a specific interest in the medial prefrontal cortex (mPFC) area, we quantified the concentration of amino acid neurotransmitters including GABA ((r-aminobutyric acid)), Glu (Glutamate), and Glx (Glutamate + Glutamine) using (1)H-MRS technology. Moreover, we conducted Pearson correlation analysis between the ALFF value and neurotransmitter concentration to find out the functional-biochemical relation in mPFC area. The relationship between the metabolites concentration and MDD symptomatology was also examined through Spearman correlation analysis. RESULTS:We found that the female MDD patients showed increased neuronal spontaneous activity in left medial prefrontal cortex (mPFC) and left middle frontal cortex, with decreased ALFF level in right putamen and right middle temporal cortex (p<0.01, Alphasim corrected). The ALFF in mPFC was shown positively correlated with Glu concentration in female MDD patients (r=0.67, p=0.023). The Glu concentration in mPFC was positively correlated with patients HAMA scores (r=0.641, p=0.033). LIMITATIONS:The relatively small sample size, metabolite information acquired only in mPFC and not all patients were unmedicated are the major limitations of our study. CONCLUSIONS:Using combined fMRI-MRS methods, we found increased spontaneous neuronal activity was correlated with Glu concentration in mPFC of female MDD patients. Other regions including left middle frontal gyrus, right putamen and middle temporal gyrus also showed altered spontaneous neuronal activities. The abnormal intrinsic neuronal activities in fronto-cortical regions shed light on the pathogenesis underlying MDD females. The multimodal resting-state neuroimaging technique served as a useful tool for functional-biochemical investigation of MDD pathophysiology.

Alterations of plasma aspartic acid, glycine and asparagine levels in patients with major depressive disorder]

The Association Between Plasma Neurotransmitters Levels and Depression in Acute Hemorrhagic Stroke

Decreased Plasma Neuroactive Amino Acids and Increased Nitric Oxide Levels in Melancholic Major Depressive Disorder.

Plasma Concentrations of Excitatory Amino Acids, Serine, Glycine, Taurine and Histidine in Major Depression

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Increased Glutamic Acid Decarboxylase Expression in the Hypothalamic Suprachiasmatic Nucleus in Depression

Increased Ratio of Mature BDNF to Precursor-Bdnf in Patients with Major Depressive Disorder with Severe Anhedonia.

Plasma metabolites were associated with spatial working memory in major depressive disorder

Serum Levels of Excitatory Amino Acids, Serine, Glycine, Histidine, Threonine, Taurine, Alanine and Arginine in Treatment‐resistant Depression: Modulation by Treatment with Antidepressants and Prediction of Clinical Responsivity

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

A Sensitive and Practical RP-HPLC-FLD for Determination of the Low Neuroactive Amino Acid Levels in Body Fluids and Its Application in Depression

Proton magnetic resonance spectroscopy of N -acetyl aspartate in first depressive episode and chronic major depressive disorder: A systematic review and meta-analysis

The Plasma IL-18, MIP-1α, MCP-1, SDF-1 and Rantes in Patients with Majior Depression

Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings

Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.

A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder

Increased Plasma Levels of Competing Amino Acids, Rather Than Lowered Plasma Tryptophan Levels, Are Associated with a Non-Response to Treatment in Major Depression.

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder

Secondary analysis of neurotransmitter metabolism and cognitive function in first-diagnosed, drug-naïve adult patients with major depressive disorder

Myo-inositol, Glutamate, and Glutamine in the Prefrontal Cortex, Hippocampus, and Amygdala in Major Depression

Investigating Neuroplasticity Changes Reflected by BDNF Levels in Astrocyte-Derived Extracellular Vesicles in Patients with Depression